DHEA-S (dehydroepiandrosterone sulfate) peaks between ages 20 and 29 and declines steadily at roughly 2 to 3 percent per year thereafter, leaving most adults with only 10 to 20 percent of their peak levels by their 70s. Normal ranges vary significantly by age and sex, making age-matched reference values essential for interpreting test results. Low DHEA-S is associated with increased cardiovascular risk, reduced muscle mass, insulin resistance, and immune decline. Sleep quality, stress management, dietary composition, and moderate exercise are the most evidence-supported lifestyle factors for supporting natural DHEA production.
What DHEA-S Is and Why It Is the Preferred Marker
DHEA and DHEA-S are related but distinct compounds. DHEA is produced in the adrenal glands and rapidly converted to DHEA-S in the liver and adrenal tissue through sulfation. DHEA-S is the sulfated storage form that circulates in blood at concentrations several hundred times higher than unconjugated DHEA.
The reason clinicians order DHEA-S rather than DHEA for most purposes is stability. DHEA follows a circadian rhythm and fluctuates with ACTH secretion, requiring carefully timed blood draws for meaningful measurement. DHEA-S is highly stable throughout the day, making a single morning blood draw a reliable snapshot of adrenal androgen production capacity without the timing complications of DHEA measurement.
DHEA-S is primarily produced in the adrenal cortex, specifically the zona reticularis, which is the innermost layer of the adrenal gland. A smaller contribution comes from the gonads and, in the brain, from local synthesis. It is a key precursor for both testosterone and estrogen, and its decline with age reduces the raw material available for downstream sex hormone production throughout the body.
Normal DHEA-S Ranges by Age and Sex
Understanding whether a DHEA-S result is normal requires comparing it to an age- and sex-specific reference range, not a general population value. Levels that are entirely normal for a 25-year-old represent significant decline when they occur in a 45-year-old.
The table below shows approximate normal DHEA-S ranges across adulthood. Individual laboratory reference values may differ slightly based on the assay method used, and results should always be interpreted against the specific lab's printed range rather than any generalized chart.
| Age Range | Women (mcg/dL) | Men (mcg/dL) |
|---|---|---|
| 18 to 19 | 145 to 395 | 108 to 441 |
| 20 to 29 | 65 to 380 | 280 to 640 |
| 30 to 39 | 45 to 270 | 120 to 520 |
| 40 to 49 | 32 to 240 | 95 to 530 |
| 50 to 59 | 26 to 200 | 70 to 310 |
| 60 to 69 | 13 to 130 | 42 to 290 |
| 70 and over | 10 to 90 | 28 to 175 |
Men consistently show higher DHEA-S than women at every age, with the gap widest during peak reproductive years. Both sexes show the same pattern of peak in the early 20s followed by sustained linear decline through the remainder of adult life.
Why DHEA-S Declines With Age
The decline in DHEA-S is driven primarily by structural changes in the adrenal gland itself. The zona reticularis, which is responsible for most DHEA-S production, undergoes progressive thinning beginning in the late 20s. This anatomical change, sometimes called adrenarche reversal or adrenopause, is distinct from the declines seen in other adrenal zones and from changes in cortisol production.
The clinical distinction matters. Cortisol production is maintained by the zona fasciculata, which does not undergo the same age-related thinning as the zona reticularis. This produces the characteristic age-related hormonal imbalance where cortisol remains relatively stable while DHEA-S falls, resulting in a rising cortisol-to-DHEA ratio over time. This ratio shift has clinical significance: high cortisol combined with low DHEA-S is associated with accelerated biological aging, reduced immune function, and increased vulnerability to stress-related health consequences.
How the relationship between cortisol and adrenal hormones changes across the lifespan and through hormonal transitions covers the perimenopause and menopause context in which DHEA-S decline is most clinically significant for women, where adrenal androgen production becomes the primary source of sex hormone precursors as ovarian output falls.
What Elevated DHEA-S Indicates
While the primary concern in middle-aged and older adults is declining DHEA-S, abnormally elevated levels require investigation. Markedly elevated DHEA-S, typically defined as above 600 mcg/dL in adults, can indicate excess adrenal androgen production from several causes.
Adrenal tumors are the most serious concern, particularly adrenocortical carcinomas, which frequently produce large quantities of DHEA-S. Benign adrenal adenomas can also produce elevated DHEA-S, though typically to a lesser degree. Congenital adrenal hyperplasia (CAH), particularly the non-classic form that may not present until adulthood, produces elevated adrenal androgens including DHEA-S through enzymatic defects in cortisol synthesis.
Polycystic ovary syndrome (PCOS) is the most common cause of mildly to moderately elevated DHEA-S in women of reproductive age, reflecting the combined adrenal and ovarian androgen excess characteristic of the condition.
Clinical signs associated with elevated DHEA-S in women include hirsutism, cystic acne, androgenic alopecia, menstrual irregularities, and virilization in more severe cases. Any result significantly above the age-matched upper reference limit warrants clinical evaluation rather than lifestyle-only management.
What Low DHEA-S Indicates
Low DHEA-S below the age-matched lower reference limit can indicate several distinct conditions depending on the clinical context.
Adrenal insufficiency from any cause, including Addison's disease, secondary adrenal insufficiency from pituitary disease, or prolonged glucocorticoid use, reduces DHEA-S production alongside cortisol. In these contexts, low DHEA-S is part of a broader hormonal deficiency requiring medical treatment rather than lifestyle intervention.
Age-related decline that reaches the lower end of the age-matched range represents the most common scenario in adults over 50. This is not a disease state requiring treatment, but it is associated with a constellation of health outcomes that benefit from attention.
The health associations with low DHEA-S documented in observational studies include increased cardiovascular risk particularly in women under 65, insulin resistance and metabolic syndrome, reduced bone mineral density, impaired immune function with increased susceptibility to infection, reduced muscle mass and physical functioning, and elevated inflammatory markers including CRP and IL-6.
How age-related hormonal changes overlap with physical performance decline and what targeted support looks like provides the physical health context in which DHEA-S decline and its associated muscle and metabolic changes are practically relevant for active adults.
Sleep and DHEA-S Production
Sleep is the most impactful lifestyle variable for supporting DHEA production. DHEA-S follows a weak but consistent diurnal pattern tied to the cortisol rhythm, with production partly influenced by ACTH pulsatility during sleep. More significantly, the broader hormonal environment of sleep, including growth hormone release during slow-wave sleep and the overnight HPA axis suppression that keeps the cortisol-to-DHEA ratio from worsening, determines how well the adrenal zona reticularis maintains its output capacity over time.
Chronic sleep deprivation elevates cortisol and accelerates the cortisol-to-DHEA ratio shift. It also impairs the overnight hormonal recalibration through which adrenal function is maintained. Adults with consistently poor sleep quality show lower DHEA-S than age-matched peers with adequate sleep in observational research.
How sleep quality governs hormone regulation and the physiological recovery that adrenal function depends on covers the mechanism through which sleep architecture, particularly slow-wave sleep, protects adrenal and hormonal function over time.
Chronic Stress and the Cortisol-DHEA Imbalance
Chronic psychological stress is one of the most consistent suppressors of DHEA-S in observational and interventional research. The mechanism is partly direct and partly indirect.
The direct pathway involves the preferential allocation of adrenal zona reticularis resources toward cortisol production under sustained HPA axis activation. Pregnenolone, the shared precursor from which both cortisol and DHEA are synthesized, is diverted toward cortisol production under chronic stress conditions, reducing DHEA-S output.
The indirect pathway involves the elevated cortisol-to-DHEA ratio from chronic stress activating glucocorticoid receptor signaling that further suppresses adrenal androgen production in a self-reinforcing pattern.
Mindfulness-based stress reduction, yoga, and meditation have all demonstrated modest but consistent improvements in DHEA-S levels alongside cortisol reductions in controlled studies. These improvements reflect genuine changes in HPA axis regulation rather than placebo effects, because the serum measurements are objective. Visualizing stress relief and its physiological effects on adrenal function covers the stress management techniques most documented to produce measurable hormonal outcomes.
Dietary Factors That Support DHEA-S Levels
Dietary composition influences DHEA-S through several mechanisms including blood sugar regulation, inflammatory load, and the micronutrient availability required for adrenal steroidogenesis.
The strongest dietary associations with higher DHEA-S in epidemiological research are higher vegetable protein intake, lower sugar-sweetened beverage consumption, and lower refined grain intake. These associations are consistent across age groups and sex categories, suggesting a real nutritional effect rather than a confounding relationship with general health behaviors.
Blood sugar stability is particularly relevant. High glycemic index diets produce repeated insulin spikes that stimulate cortisol production through glucose management demands, worsening the cortisol-to-DHEA ratio over time. How blood sugar stability affects hormonal balance and metabolic health covers the glucose-cortisol-adrenal connection that makes dietary carbohydrate quality a meaningful variable in adrenal hormone support.
Omega-3 fatty acids reduce the chronic inflammatory markers including IL-6 and TNF-alpha that are associated with lower DHEA-S in observational research. Their anti-inflammatory effects support the hormonal environment in which DHEA production can be maintained. How omega-3s reduce systemic inflammation and support healthy aging is directly relevant to anyone addressing DHEA-S decline as part of a broader healthy aging strategy.
Exercise and DHEA-S
Exercise has a bidirectional relationship with DHEA-S that depends on type, intensity, and duration. Moderate aerobic exercise and resistance training at appropriate volumes are consistently associated with higher DHEA-S levels in cross-sectional studies comparing active and sedentary adults.
The mechanism involves several parallel pathways. Regular exercise reduces baseline cortisol through improved HPA axis negative feedback efficiency. It lowers chronic inflammatory markers that suppress adrenal androgen production. It maintains the metabolic health including insulin sensitivity that is associated with higher DHEA-S. It also preserves the muscle mass that DHEA-S partially mediates.
Acute high-intensity exercise produces a temporary DHEA-S rise that may reflect transient adrenal stimulation, but this acute response does not translate to sustained elevation without consistent training. How exercise supports healthy aging, hormonal balance, and long-term physical function provides the physical health framework in which exercise-supported DHEA-S maintenance is most practically meaningful.
The Role of NAD and Mitochondrial Function
An underappreciated connection exists between NAD levels and DHEA production. NAD is required for the enzymatic activity of the cytochrome P450 enzymes responsible for adrenal steroidogenesis, including the conversion of cholesterol to DHEA precursors. As NAD levels decline with age, a parallel degradation of steroidogenic enzyme function occurs.
This connection suggests that interventions supporting NAD levels, including NMN and NR supplementation, may indirectly support DHEA-S production by maintaining the enzymatic infrastructure required for adrenal hormone synthesis. How NMN and NR support mitochondrial function and age-related cellular energy decline covers this mitochondrial and enzymatic context in the broader longevity framework within which DHEA-S decline is one of several parallel aging biomarkers.
DHEA Supplementation: Benefits, Risks, and Context
DHEA is available as an over-the-counter supplement in the United States, though it is prescription-only in many other countries. Supplementation with 25 to 50 mg per day has demonstrated modest improvements in wellbeing, libido, and bone density in postmenopausal women with low DHEA-S in several controlled trials. Evidence in other populations is less consistent.
The risks of supplementation are meaningful and require consideration. Exogenous DHEA is converted to testosterone and estrogen in peripheral tissues, and the degree of conversion varies between individuals based on enzyme activity in skin, fat, and liver. Women can experience androgenic side effects including acne and hirsutism. Men may see estrogen conversion effects. People with hormone-sensitive conditions including breast, prostate, or ovarian cancer should not supplement without oncological guidance.
Supplementation also suppresses endogenous adrenal DHEA production through negative feedback, which is the opposite of the natural restoration approach that lifestyle interventions pursue. Medical guidance is appropriate before starting DHEA supplementation at any dose.
A proactive approach to hormonal health, physical resilience, and long-term biological aging frames the correct context for DHEA-S management: lifestyle optimization supports natural production over time, while supplementation is a medical decision requiring appropriate hormonal monitoring.
Frequently Asked Questions
What is a normal DHEA-S level for my age
Normal DHEA-S ranges vary significantly by age and sex. Women aged 20 to 29 have a normal range of 65 to 380 mcg/dL, declining to 13 to 130 mcg/dL by their 60s. Men aged 20 to 29 range from 280 to 640 mcg/dL, declining to 28 to 175 mcg/dL by age 70. Always compare results to your specific laboratory's age- and sex-matched reference range, as assay methods differ between facilities.
Why does DHEA-S decline with age
The primary driver is structural thinning of the adrenal zona reticularis, the gland layer responsible for most DHEA-S production, beginning in the late 20s. This process is separate from cortisol production decline, which is why cortisol often remains relatively stable as DHEA-S falls. Additional contributors include chronic stress, poor sleep, inflammatory burden, and declining NAD levels that impair adrenal steroidogenic enzyme function.
Can lifestyle changes increase DHEA-S naturally
Yes, modestly. Consistent adequate sleep, chronic stress reduction through mindfulness or yoga, dietary improvements including higher vegetable protein and lower refined sugar intake, and regular moderate exercise are all associated with higher DHEA-S in research studies. These associations are real but modest. Lifestyle interventions support natural production capacity rather than dramatically raising levels, making them most effective in people with lifestyle-driven suppression rather than structural adrenal decline.
What are the health risks of low DHEA-S
Low DHEA-S below the age-matched reference range is associated with increased cardiovascular risk particularly in women under 65, insulin resistance, reduced bone mineral density, impaired immune function, elevated chronic inflammatory markers, reduced muscle mass and physical performance, and lower sense of wellbeing. These associations are observational, meaning low DHEA-S marks rather than necessarily causes these conditions, but the pattern is consistent across multiple large population studies.
Should I take DHEA supplements to raise my levels
DHEA supplementation has shown modest benefits in wellbeing, libido, and bone density in postmenopausal women with documented low DHEA-S in controlled trials. However, it carries risks including androgenic side effects in women, estrogen conversion in men, and suppression of endogenous production through negative feedback. It is prescription-only in many countries outside the US. Medical supervision with hormonal monitoring is appropriate before starting supplementation, and it is not recommended for people with hormone-sensitive cancers or conditions without oncological guidance.
What is the difference between DHEA and DHEA-S
DHEA is the unconjugated form that follows a circadian rhythm and fluctuates with ACTH secretion throughout the day. DHEA-S is the sulfated storage form produced primarily by the adrenal zona reticularis. DHEA-S circulates at concentrations several hundred times higher than DHEA, is highly stable throughout the day, and provides a reliable snapshot of adrenal androgen production capacity from a single blood draw. DHEA-S is the clinically preferred marker for adrenal androgen assessment for this reason.
Can stress suppress DHEA-S levels
Yes. Chronic psychological stress activates the HPA axis and diverts the shared hormonal precursor pregnenolone preferentially toward cortisol production at the expense of DHEA synthesis. It also elevates cortisol chronically, worsening the cortisol-to-DHEA ratio that is a key marker of adrenal hormonal balance. Multiple controlled studies have shown that stress reduction practices including mindfulness meditation and yoga produce measurable increases in DHEA-S alongside cortisol reductions over 8 to 12 weeks of consistent practice.
Â